Immunovant, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC IMVT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

134,441

Value ($000)

3,417

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	3,417	0.0%	134,441	12/31/2025
2025 Q3	11/14/2025	1,728	0.0%	107,224	9/30/2025
2025 Q2	8/14/2025	3,204	0.0%	200,260	6/30/2025
2025 Q1	5/19/2025	2,394	0.0%	140,091	3/31/2025
2024 Q4	2/14/2025	6,917	0.0%	279,252	12/31/2024
2024 Q3	11/14/2024	8,862	0.0%	310,830	9/30/2024
2024 Q2	8/14/2024	8,461	0.0%	320,508	6/30/2024
2024 Q1	5/15/2024	6,657	0.0%	206,031	3/31/2024
2023 Q4	2/14/2024	8,744	0.0%	207,552	12/31/2023
2023 Q3	11/13/2023	3,183	0.0%	82,916	9/30/2023
2023 Q2	8/11/2023	802	0.0%	51,722	6/30/2023
2023 Q1	5/15/2023	802	0.0%	51,722	3/31/2023
2022 Q4	2/14/2023	777	0.0%	43,754	12/31/2022
2022 Q3	11/14/2022	208	0.0%	37,345	9/30/2022
2022 Q2	8/12/2022	203	0.0%	51,942	6/30/2022
2022 Q1	5/16/2022	286	0.0%	51,942	3/31/2022
2021 Q4	2/14/2022	443	0.0%	51,942	12/31/2021
2021 Q3	11/15/2021	451	0.0%	51,942	9/30/2021
2021 Q2	8/16/2021	636	0.0%	60,197	6/30/2021
2021 Q1	5/14/2021	698	0.0%	43,547	3/31/2021
2020 Q4	3/1/2021	2,062	0.0%	44,641	12/31/2020
2020 Q3	11/13/2020	704	0.0%	20,000	9/30/2020
2020 Q2	8/14/2020	217	0.0%	8,900	6/30/2020